In ovarian cancer, like in other cancer entities, the expression of the ESR2 gene coding for ERβ is reduced compared to normal tissues, and low levels of this receptor have been reported to be associated with a more aggressive cancer phenotype and with poor OC survival due to the role of ERβ as a tumor suppressor [31,40,44,94]. This evidence concerns the gene ESR2 and neoplasm.